Christopher Durant Turner - 17 May 2022 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Medical Officer
Signature
/s/ Deborah A. Miller, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
17 May 2022
Net transactions value
+$99,995
Form type
4
Filing time
19 May 2022, 16:36:05 UTC
Previous filing
05 Jan 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $99,995 +14,513 $6.89* 14,513 17 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -14,513 -4.3% $0.000000 326,665 17 May 2022 Class A Common Stock 14,513 $6.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as follows: 25% of the shares vested on March 22, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Limited Power of Attorney